Juliet Moritz | Senior VP Strategic Solutions and Patient Centricity
Ergomed

Juliet Moritz is a dynamic and results-driven leader with over 35 years of experience in the pharmaceutical and biotechnology industry. As the Senior Vice President of Strategic Solutions and Patient Centricity at Ergomed, she is dedicated to driving innovation and improving patient outcomes in the rare disease space.

Juliet is known for her strategic vision and ability to develop and implement patient-centric solutions that address the unique challenges faced by individuals with rare diseases. Her expertise lies in building strong partnerships with key stakeholders, including patients, advocacy groups, healthcare providers, and biotechnology and pharmaceutical companies, to ensure the successful development and commercialization of orphan drugs.

With a background in clinical research and project management, Juliet brings a wealth of knowledge to her role at Ergomed. She is passionate about advancing the field of orphan drugs and rare diseases, and is committed to making a meaningful impact on the lives of patients and their families.

Juliet is a sought-after speaker and thought leader in the industry, and is honored to be sharing her insights at the World Orphan Drug Congress USA 2025. Her innovative approach to patient-centricity and strategic solutions is sure to inspire and inform attendees at this premier event.